Athira Pharma
ATHA
ATHA
57 hedge funds and large institutions have $7.18M invested in Athira Pharma in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
88% less capital invested
Capital invested by funds: $58.8M → $7.18M (-$51.6M)
Holders
57
Holding in Top 10
–
Calls
$52K
Puts
$46K
Top Buyers
| 1 | +$159K | |
| 2 | +$112K | |
| 3 | +$89.3K | |
| 4 |
Renaissance Technologies
New York
|
+$80.9K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$70.1K |
Top Sellers
| 1 | -$8.36M | |
| 2 | -$3.43M | |
| 3 | -$2.38M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.34M |
| 5 |
NFGH
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$477K |